FOXA1 and breast carcinoma: Given that FOXA1 has been shown to function in response to proinflammatory signaling and endocrine resistance in breast cancer cells and in regulatory T cells49–51, it will be critical to discriminate FOXA1-dependent, cell type-specific effects.